23rd July, 2015

Atosiban 6.75mg/0.9ml & 37.5mg/5ml IV

Bowmed Ibisqus is delighted to announce the launch of Atosiban IV on behalf of the MA Holder Ibigen Srl. This product will be distributed in a 6.75mg/0.9ml ampoule and a 37.5mg/5ml vial.

Please note that future batches of the 37.5mg/5ml vial will also include a warning on the front of the carton and label that the product must be diluted prior to use. There will also be an update to the Patient Information Leaflet in subsequent batches later this year. Please refer to the Products Section of our website for the latest SPC and PIL or click here for further information regarding the packaging changes.

The product has been listed with our nominated distributors and stock is available on a regional basis for any live contracts. This product is a refrigerated item. If you would like to discuss Atosiban IV or any of our other products please contact us directly on +44 (0)845 6436 703 or email us